Efficacy against subcutaneous or intracranial murine GL261 gliomas in relation to the concentration of the vascular-disrupting agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), in the brain and plasma

Author： Yung Raymond   Seyfoddin Vahid   Guise Christopher   Tijono Sofian   McGregor Ailsa   Connor Bronwen   Ching Lai-Ming  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.73, Iss.3, 2014-03, pp. : 639-649

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacokinetics of 5,6-dimethylxanthenone-4-acetic acid (AS1404), a novel vascular disrupting agent, in phase I clinical trial

By Jameson M.   Baguley B.   Kestell P.   Zhao L.   Paxton J.   Thompson P.   Waller S.  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 5, 2007-04 ,pp. : 681-687

Springer Publishing Company

Access to resources Recommend Favorite

Gender differences in the metabolism and pharmacokinetics of the experimental anticancer agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)

By Zhou Shufeng   Kestell Philip   Tingle Malcolm   Paxton James  

Cancer Chemotherapy and Pharmacology, Vol. 49, Iss. 2, 2002-02 ,pp. : 126-132

Springer Publishing Company

Access to resources Recommend Favorite

NF-kappa B activation in vivo in both host and tumour cells by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)

By Woon S.-T.   Zwain S.   Schooltink M.A.   Newth A.L.   Baguley B.C.   Ching L.-M.  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1176-1183

Elsevier

Access to resources Recommend Favorite

The effects of the vascular disrupting agents combretastatin A-4 disodium phosphate, 5,6-dimethylxanthenone-4-acetic acid and ZD6126 in a murine tumour: A comparative assessment using MRI and MRS

By Breidahl Tomas   Nielsen Flemming   Stødkilde-Jørgensen Hans   Maxwell Ross   Horsman Michael  

Acta Oncologica, Vol. 45, Iss. 3, 2006-04 ,pp. : 306-316

Informa Healthcare

Access to resources Recommend Favorite

Potentiation of the anti-tumour effect of hyperthermia by combining with the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid

By Murata R.   Overgaard J.   Horsman M. R.  

International Journal of Hyperthermia, Vol. 17, Iss. 6, 2001-11 ,pp. : 508-519

Informa Healthcare

Access to resources Recommend Favorite